[Webinar] FibroGen Update on Pamrevlumab & Enrolling Non-Ambulatory Study - October 2017

[Webinar] FibroGen Update on Pamrevlumab & Enrolling Non-Ambulatory Study - October 2017Подробнее

[Webinar] MissionDMD: FibroGen’s Anti-Fibrosis Program - May 2016Подробнее

[Webinar] MoveDMD Trial Open-Label Extension Results - October 2017Подробнее

Recently Reported Updates - FibroGen (PPMD's 2021 Virtual Annual Conference)Подробнее

[Webinar] Mission DMD: FibroGen’s Anti-Fibrosis Program - February 2017Подробнее

Trial Update: Pamrevlumab - Fibrogen [PPMD's 2017 Connect Conference]Подробнее

[Webinar] Summit's Utrophin Modulation Program - January 2017Подробнее

Elias Kouchakji, MD: Importance of Non-Ambulatory Patients in DMD TrialsПодробнее

In the Pipeline: Combating Fibrosis & Inflammation - FibroGenПодробнее

[Webinar] Vamorolone (VBP15) Clinical Trials in Duchenne - January 2017Подробнее

[Webinar] Italfarmaco Provides Givinostat Update - January 2018Подробнее

SCAI 2024: ENGULF StudyПодробнее